Malcolm De Lara
About Malcolm De Lara
Malcolm De Lara is a Senior Research Coordinator at NYU Langone Health with extensive experience in research coordination and regulatory roles.
Current Role at NYU Langone Health
Malcolm De Lara currently serves as a Senior Research Coordinator at NYU Langone Health. He has been in this role since 2019 in New York, New York. His responsibilities include overseeing monthly meetings for NRG Oncology-sponsored cooperative group trials, managing the roster for neuro-oncology disease management group REDCap compliance monitoring, and providing back-up coverage for Gynecology & Hematology disease management groups. Additionally, he ensures compliance with Covid-19 safety regulations for all sponsored individuals and co-workers.
Previous Roles at NYU Langone Health
Malcolm De Lara has held multiple roles at NYU Langone Health. From 2017 to 2018, he worked as a Regulatory Specialist. Prior to that, he served as a Research Coordinator from 2017 to 2019. His earliest role at the institution was as an Associate Research Coordinator from 2016 to 2017. These positions contributed significantly to his expertise in research coordination, regulatory affairs, and compliance monitoring.
Early Career at Drexel University College of Medicine
Before joining NYU Langone Health, Malcolm De Lara worked at Drexel University College of Medicine. He held various positions including Histotechnology Lab Assistant from 2014 to 2015, Microbiology Lab Assistant in 2014, and Neuroscience Lab Assistant in 2013. His work at Drexel provided foundational experience in laboratory techniques and scientific research.
Educational Background
Malcolm De Lara holds a Master of Science in Neuroscience/Histotechnology from Drexel University College of Medicine, completed between 2013 and 2015. He also earned a Bachelor of Science in Neuroscience from King's College, where he studied from 2009 to 2013. His academic training has equipped him with in-depth knowledge in neuroscience and histotechnology.
Contributions to Research and Compliance
Malcolm De Lara has contributed to the development of institutional serious adverse event forms and RANO tumor measurement forms for IRB approval. His role in these initiatives highlights his expertise in research compliance and regulatory affairs. He also oversees monthly meetings for NRG Oncology-sponsored cooperative group trials and manages compliance monitoring for neuro-oncology disease management groups using REDCap.